GLP-1 Drugs: Brand Companies Push FDA to Limit Compounding Brand companies who own GLP-1 products have been pushing the Food and Drug Administration (FDA) to limit their compounding
The most common side effects are gastrointestinal, including nausea (1220% of patients), diarrhea (716%), decreased appetite, and constipation (57%)
Want an instant hangover cure
As estrogen levels drop with fat loss, vaginal tissues can become thinner and less lubricated, which may cause dryness or pain during sex
The Bottom Line Anti-inflammatory nutrition isnt a trendits a foundation for GLP-1 success
This makes provider review, product sourcing, dosing, and monitoring especially important